×
AllNewsImagesMaps Videos Shopping Books
Search tools
Showing results for ZIOPHARM Oncology
Search instead for ZIOPHARM Oncolgy

Alaunos winds down sole cell therapy trial, cuts 60% of staff

Fierce Biotech
Alaunos is cutting loose its sole clinical-stage asset and letting 60% of staff go less than two years after refocusing on TCR-T cell...
8 months ago

Bullish insiders at ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) loaded up on US$639k of stock earlier this year

Yahoo
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of ZIOPHARM Oncology,...
2 weeks ago

Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program

MD Anderson Cancer Center
Ziopharm Oncology, Inc., and The University of Texas MD Anderson Cancer Center today announced a new research and development agreement...
54 months ago

Ziopharm hopes to put a rough year behind it with rebrand to Alaunos Therapeutics

Fierce Biotech
Ziopharm Oncology is hoping to put the wild ride of 2021 behind it with a rebranding to Alaunos Therapeutics.
27 months ago

ZIOPHARM changes name to Alaunos Therapeutics; shares up 5% premarket

Seeking Alpha
ZIOPHARM Oncology has rebranded itself and is now known as Alaunos Therapeutics.
27 months ago

Joint Comments Regarding NIH Exclusive License to Ziopharm Oncology for Cell Therapy

Knowledge Ecology International
The license would grant Ziopharm exclusive, worldwide rights to three types of T Cell Receptors (TCRs) targeting mutated Kirsten rat sarcoma...
45 months ago

Ziopharm Eliminates 60 Positions in Strategic Workforce Reduction

BioSpace
Less than a month after appointing a new chief executive officer, Ziopharm Oncology announced a restructure that has resulted in over 50% of...
31 months ago

Aldevron Announces Agreement with Ziopharm Oncology for neoGMP® Production of Sleeping Beauty Plasmid DNA ...

Business Wire
Aldevron announced an agreement with Ziopharm Oncology to produce plasmid DNA for T cell therapy of solid tumors, developing the neoGMP®...
46 months ago

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

GlobeNewswire
(“Ziopharm” or the “Company”) (Nasdaq: ZIOP), a clinical-stage oncology-focused cell therapy company, today highlighted recent operational and...
27 months ago

Form DFAN14A ZIOPHARM ONCOLOGY INC Filed by: Postma Robert W

StreetInsider.com
UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 14A. (Rule 14a-101). INFORMATION REQUIRED IN CONSENT...
42 months ago